Package 0002-7715-63

Brand: basaglar kwikpen

Generic: insulin glargine
NDC Package Sample

Package Facts

Identity

Package NDC 0002-7715-63
Digits Only 0002771563
Product NDC 0002-7715
Description

1 SYRINGE in 1 CARTON (0002-7715-63) / 3 mL in 1 SYRINGE

Marketing

Marketing Status
Marketed Since 2016-07-15
Brand basaglar kwikpen
Generic insulin glargine
Sample Package Yes

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "3c2283e6-2844-44d2-a447-579b07e77c27", "openfda": {"nui": ["M0011417", "N0000175453"], "unii": ["2ZM8CX04RZ"], "rxcui": ["847230", "1736863", "2268064", "2268065"], "spl_set_id": ["0ad21db3-2b1c-4ed9-a687-bdd6a74d0aae"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 SYRINGE in 1 CARTON (0002-7715-59)  / 3 mL in 1 SYRINGE (0002-7715-01)", "package_ndc": "0002-7715-59", "marketing_start_date": "20160617"}, {"sample": true, "description": "1 SYRINGE in 1 CARTON (0002-7715-63)  / 3 mL in 1 SYRINGE", "package_ndc": "0002-7715-63", "marketing_start_date": "20160715"}], "brand_name": "BASAGLAR KwikPen", "product_id": "0002-7715_3c2283e6-2844-44d2-a447-579b07e77c27", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Insulin Analog [EPC]", "Insulin [CS]"], "product_ndc": "0002-7715", "generic_name": "Insulin glargine", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BASAGLAR", "brand_name_suffix": "KwikPen", "active_ingredients": [{"name": "INSULIN GLARGINE", "strength": "100 [iU]/mL"}], "application_number": "BLA205692", "marketing_category": "BLA", "marketing_start_date": "20151216", "listing_expiration_date": "20271231"}